Anesthesia for Catheter Aortic Valve ImplantATIOn Registry
Launched by DEUTSCHES HERZZENTRUM MUENCHEN · Jul 8, 2011
Trial Information
Current as of June 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Anesthesia for Catheter Aortic Valve Implantation Registry, is focused on understanding how anesthesia is managed during a specific heart procedure known as Transcatheter Aortic Valve Implantation (TAVI). TAVI is a newer option for patients with severe heart problems who might not be able to undergo traditional heart surgery. The researchers want to learn more about the challenges and techniques that anesthesiologists face during this procedure to improve patient safety and outcomes.
To participate in this trial, you need to be a patient scheduled for a TAVI procedure. The study is open to both men and women, and participants generally range in age from 65 to 74 years. If you decide to take part, you can expect to share your experiences during the procedure, which will help healthcare providers make TAVI safer and more effective for everyone. It's important to note that if a patient chooses not to participate, that decision will be respected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patients undergoing transcatheter aortic valve implantation (TAVI)
- Exclusion Criteria:
- • - Refusal by patient
About Deutsches Herzzentrum Muenchen
Deutsches Herzzentrum München (German Heart Center Munich) is a leading institution in cardiovascular medicine, dedicated to advancing research, treatment, and education in heart health. Affiliated with the Technical University of Munich, the center specializes in innovative clinical trials aimed at improving diagnostic and therapeutic approaches for heart diseases. With a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to patient-centered care, Deutsches Herzzentrum München is at the forefront of developing novel interventions and enhancing clinical outcomes in cardiovascular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Munich, Bavaria, Germany
Patients applied
Trial Officials
Patrick N Mayr, M.D.
Principal Investigator
Deutsches Herzzentrum München, Technische Universität München
Michael Joner, MD, Prof.
Principal Investigator
Deutsches Herzzentrum München, Technische Universität München
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials